Common questions
FOX04-DRI — questions, answered plainly.
6 research-context questions about FOX04-DRI. Answers stay neutral and reference what is published in the peer-reviewed literature — no dosing, no human-use guidance, no extrapolation beyond what the cited studies report.
- 01
What is FOX04-DRI?
FOX04-DRI (FOXO4-D-Retro-Inverso) is a synthetic D-retro-inverso peptide designed by the Peter de Keizer group to interfere with the FOXO4-p53 interaction in senescent cells. The D-retro-inverso configuration is intended to extend protease resistance compared with the L-peptide.
- 02
Is FOX04-DRI FDA-approved?
No. FOX04-DRI is preclinical only — no FDA, MHRA, or EMA approval exists, and no peer-reviewed human clinical trials are indexed on PubMed.
- 03
What does the cited FOX04-DRI research show?
Born 2023 (Circulation, PMID 36515093) reports attenuated pulmonary hypertension and senescence markers in a bleomycin mouse model of pulmonary fibrosis. Zhang 2020 (Aging, PMID 31959736) reports clearance of senescent Leydig cells and partial restoration of testosterone secretion in aged C57BL/6 mice.
- 04
What is the mechanism of FOX04-DRI?
It is reported to compete with endogenous FOXO4 for binding to p53 in senescent cells, releasing p53 to the nucleus and triggering apoptosis selectively in cells with a senescence-associated FOXO4-p53 retention pattern.
- 05
What model types are the studies in?
All cited studies are preclinical — rodent in vivo work (bleomycin mouse pulmonary fibrosis, aged C57BL/6 mice) and in vitro Leydig-cell senescence assays. No human cohorts have been published.
- 06
What are the evidence caveats for FOX04-DRI?
No controlled human trials are indexed on PubMed. Senolytic off-target effects on non-senescent cell populations require further independent characterisation. Findings are model-specific and are not extrapolated to therapeutic use.
Important
These answers are not medical advice.
FOX04-DRI is referenced in research literature only. Palthera does not provide dosage, cycling, stacking, or injection guidance, and content is not intended to support consumer or therapeutic use. Speak to a qualified clinician for any health decisions.